Student Precarity and Psychiatry

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssistance Publique - Hôpitaux de Paris

About this trial

Since the COVID-19 pandemic, mental health disorders have increased significantly, particularly among young people. In France, the proportion of young people aged 18 to 25 suffering from depression almost doubled between 2017 and 2021. This phenomenon particularly affects students, who are already identified as being at greater risk of mental health disorders than the general population. Medical students seem to be particularly vulnerable: in 2021, a national study showed very high rates of depression and suicidal thoughts in this population. The main factor associated with depression was the feeling of financial hardship.

Students often face multiple forms of insecurity. Financially, they have limited resources and struggle to cover their basic needs such as housing, food and healthcare. Socially, many experience significant isolation, particularly when they are away from their families or under pressure from their studies. All of this has a significant impact on their mental health. Unfortunately, many students do not seek help due to lack of time, resources, or awareness of support services. The 2021 study showed that only one-third of medical students suffering from depression received appropriate treatment.

The aim of our study is to assess the impact of precariousness on the onset of psychiatric disorders and on the use or non-use of healthcare services.

Our study will involve nearly 45,000 students from PSL and UPC universities. It is based on a longitudinal cohort (via questionnaires) over three years. The aim is to identify precisely the different aspects of student precariousness (housing, transport, isolation, economic difficulties, etc.) and their link with psychological distress. The study will measure the extent of the phenomenon and identify modifiable factors that could be targeted by preventive measures. The results will enable us to better target preventive measures and propose concrete solutions to improve students' well-being and promote their success.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Student enrolled at Paris Sciences et Lettres University (PSL, 17,000 students) or the Faculty of Health Sciences at Paris Cité University (UPC, 28,000 students),

Aged 18 or over,

Fluent in French,

Affiliated to a health insurance.

Disqualifiers

Applicants under the age of 18,

Not enrolled at PSL universities or the UPCS Faculty of Health,

Insufficient level of French.

Trial population

All students enrolled at Paris Sciences et Lettres University or the Faculty of Health Sciences at Paris Cité University.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Questionnaires

    Other intervention

    Questionnaires

Treatment groups

45,000 Participants
are divided into 2 treatment groups
Group A: Health students1 intervention
Group B: Non-health students1 intervention

Trial outcomes

Primary outcomes

1

Composite International Diagnostic Interview Short-Form (CIDI-SF)

12-months prevalence Major Depressive Disorder and suicidal thoughts Composite International Diagnostic Interview Short-Form (CIDI-SF)

Time frame
Day 0
2

Composite International Diagnostic Interview Short-Form (CIDI-SF)

12-months prevalence Major Depressive Disorder and suicidal thoughts Composite International Diagnostic Interview Short-Form (CIDI-SF)

Time frame
12 months
3

Use of care

Use of care service of care professional

Time frame
Day 0
4

Use of care

Use of care service of care professional

Time frame
12 months

Secondary outcomes

1

GAD7

Prevalence of anxiety

Time frame
Day 0
2

GAD7

Prevalence of anxiety

Time frame
12 months
3

GAD7

Prevalence of anxiety

Time frame
24 months
4

SCOFF

Prevalence of Eating disorders

Time frame
Day 0

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Assistance Publique - Hôpitaux de Paris

Lead sponsor

Institut de Psychiatrie et Neurosciences de Paris (INSERM)

Collaborator

URC-CIC Paris Descartes Necker Cochin

Collaborator

This trial is not recruiting at the moment. You can still explore other options: